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http://dx.doi.org/10.1016/j.fjs.2013.
1682-606X/Copyright ª 2014, TaiwanSummary Behc¸et’s disease (BD) is a form of vasculitis which is believed to be an autoimmune
disease. The disease can be categorized as “intestinal Behc¸et’s disease” with its predominant
gastrointestinal symptoms and intestinal ulcerations. If a patient first presents with compli-
cated BD, it is difficult to diagnose because the gastrointestinal symptoms are nonspecific.
We report a case of a 22-year-old man with no previous medical history who presented with
intermittent right lower quadrant pain 2 days after an appendectomy. Intra-abdominal abscess
formation was suspected first and treated medically. Then, the disease progressed to produce
an enterocutaneous fistula and lower gastrointestinal bleeding. The diagnosis of BD was made
2 months after the patient’s first visit.
Copyright ª 2014, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Behc¸et’s disease (BD) is an inflammatory disease charac-
terized by recurrent oral aphthous ulcers and numerouseclare no conflicts of interest.
of Pathology, Chung Shan Medica
il.com (C.-H. Tsai).
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Surgical Association. Published bypotential systemic manifestations such as genital ulcers,
skin lesions, and ocular, neurologic, vascular, articular, and
gastrointestinal diseases. The most commonly involved site
in the gastrointestinal tract is the ileocecal area.l University Hospital, No. 110, Sec. 1, Chien-Kuo M. Road, Taichung
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tion occur in up to 50% of patients with intestinal BD. In
most reports, these complications are indications for sur-
gery. There are, however, no definitive laboratory tests for
BD; as a result, the diagnosis is made on the basis of clinical
findings. Because it may take several months or even years
for all of the common symptoms to appear, the diagnosis
may not be made for a long time and often retrospectively.12. Case Report
A 22-year-old, well-nourished male who denied any past
systemic disease or appropriate family history, and was
previously relatively well, came to a regional hospital for
help with a 2-day history of right lower abdominal pain. At
that hospital, he underwent an appendectomy under the
impression of acute appendicitis on the same day. No in-
hospital complications were noted and he was discharged
the next day.
However, intermittent abdominal pain was noted 2 days
after discharge, and so the patient visited our emergency
room for help. No diarrhea, constipation, tarry, or bloody
stools, bowel habit changes, fever, chills, nausea, or vom-
iting was noted.
Abdominal computed tomography (CT) was performed to
rule out intra-abdominal abscess formation (Fig. 1A and B).
He was then admitted under the impression of wound
infection and inflammatory process of the ileocecal region.Figure 1 (A, B) Inflammatory process around the ileocecal region
(C) suspicion of enterocutaneous fistula (arrow); and (D) focal cecal
free air or fluid collection. The serosal border of the cecum is intaThe wound was treated with a wet dressing, and the pa-
tient was discharged 5 days later under stable condition.
During an Outpatient Department follow-up 1 month
later, pus was found to be coming from the operative
wound, and an abdominal CT revealed an abscess with
suspicion of fistula formation (Fig. 1C). Therefore, he was
treated for a localized appendicocutaneous fistula at the
outpatient clinic for the next 2 months.
The patient was then admitted again because of poor
digestion. An abdominal CT scan prior to admission revealed
focal wall thickening of the cecum, without fat stranding of
the surrounding tissue, but no intra-abdominal free air or
fluid was noted (Fig. 1D). During admission, lower gastro-
intestinal bleeding with hemorrhagic shock occurred sud-
denly, and an emergency laparotomy was performed
following resuscitation. A right hemicolectomy was per-
formed immediately. A huge ulcer was located on the
antimesenteric side of the cecum, with nodular margins
and converging folds, which measured 7 cm  4 cm in size
and 1.5 cm in depth. Several discrete perforations with
sharp margins were present at the terminal ileum (Fig. 2).
Another deep ulcer with a volcano-like shape was noted
32 cm proximal to the ileocecal valve, and it was also
resected.
The pathology report showed nonspecific inflammatory
cell infiltration and mucosal inflammation without granu-
loma formation or venulitis (Fig. 3).
We collected samples for laboratory testing following
the operation, which included human leukocyte antigen-(arrow) without obvious abscess formation or free air bubble;
wall thickening; peripheral fat plane is relatively clean without
ct (arrow).
Figure 2 (A) Specimen; (B) typical volcano-like ulcer at the cecum, previous appendectomy wound is healing; (C) four perfo-
rations at terminal ileum located at the antimesenteric side with a sharp margin and normal thickness of the bowel wall; and (D)
non-perforated ulcer at the ileum with punched out appearance.
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anti-hepatitis C virus (anti-HCV), Extractable nuclear
antigen (anti-ENA) (SSA/SSB/Jo-1 Ab), anti-human immu-
nodeficiency virus (anti-HIV), anti-dsDNA, antinuclear
antibody (ANA), Anti-neutrophil cytoplasmic antibody
(ANCA), QuantiFERON-TB (QFT) test for tuberculosis, HCV
immunoglobulin G (IgG), Epstein-Barr virus (EBV) IgG and
EBV IgM; they were all negative. Blood cultures were per-
formed seven times during the course of treatment, and the
reports were again all negative. The pus culture which was
obtained from the subcutaneous wound revealed Escher-
ichia coli and Enterococcus faecalis.
The postoperative course was smooth and no specific
medication was required. Multiple oral ulcers presented 1
month later, and the patient was referred to an Otolaryn-
gologist. The oropharynx examination revealed two aph-
thous ulcers about 0.5 cm in diameter, with a white base
and an erythematous margin located at the base of the
tongue and the lower lip. According to the patient’s
statement, painful oral ulcers had occurred two to three
times in the past number of years. He was then referred to
a dermatologist and an ophthalmologist for further exami-
nation, and a positive pathergic reaction was observed, but
he was negative for ocular lesion.3. Discussion
BD was described in 1937 as a triad of oral ulcers, genital
ulcers, and uveitis. In 1940, Bechgaard first described the
intestinal involvement in BD. The clinical diagnostic criteria
for BD are as follows.
According to the International Study Group criteria (ISG,
1990),11 for a patient to be diagnosed with BD, the patient
must have aphthous ulcers along with two of the followingfour “hallmark” symptoms: (1) genital ulcers; (2) skin le-
sions (papulo-pustules, folliculitis, erythema nodosum,
acne in post-adolescents not on corticosteroids); (3) eye
inflammation (iritis, uveitis, retinal vasculitis, cells in the
vitreous); and (4) pathergic reaction (papule > 2 mm
diameter, 24e48 hours or more after needle-prick).
According to the International Criteria for Behc¸et’s dis-
ease (ICBD, 2006), a total score from ocular lesions (2
points), genital aphthosis (2 points), oral aphthosis (2
points), skin lesions (1 point), neurological manifestations
(1 point), vascular manifestations (1 point), and the posi-
tive pathergy test (1 point) is used for the diagnosis of BD.2
Because of the scarce clinical evidence for intestinal BD,
no specific laboratory diagnostic criteria have been devel-
oped.3 Thus, the diagnosis of intestinal BD has been based
on the clinical diagnosis of systemic BD and the identifica-
tion of intestinal ulcerations by endoscopy.
If a patient with intestinal ulcers does not satisfy the
systemic criteria at the time of colonoscopy, there will be a
delay in diagnosis.
Because there is no specific laboratory test for BD and
aphthous ulcers can also develop in cases of inflammatory
bowel disease, the endoscopic findings and pathological
examinations are important for the differential diagnosis of
BD from other inflammatory bowel diseases.
In clinical studies, fistula formation and intestinal
perforation tend to occur early in BD as compared to
Crohn’s disease (CD). Compared to the ileocecal involve-
ment in BD, ulcerative colitis usually starts in the rectum
and moves to the right colon. In the differentiation of
ileocolic Crohn’s from BD, some endoscopic findings as
described below may be helpful. Endoscopic findings of
patients with fewer than five ulcers that were oval in
shape, deep, with discrete borders, and located in the
ileocecal area, were classified as being “typical ” BD ulcers
Figure 3 (A) Abrupt mucosa breakdown (arrow). Ulcerations with nonspecific inflammatory cell infiltration of lymphocytes and
plasma cells. There was no granuloma; (B) venulitis (arrow); (C) inflammatory cells located predominantly at mucosa layer and
mucosal breakdown (arrow); less infiltration in the submucosal and muscle layer; and (D) venulitis.
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(CART) model,4 the ulcer shape was the first factor selected
that split the population sample into three groups: 96.8% of
patients with a round-shaped ulcer were diagnosed as
having intestinal BD, whereas 97.7% of those with longitu-
dinal ulcers were diagnosed with CD. The remaining pa-
tients with irregular/geographic-shaped ulcers were
further subdivided according to the distribution of lesions:
focal single or focal multiple distributions, and segmental
or diffuse distributions. Among them, 17/23 (74%) patients
with focally distributed lesions were confirmed as having
intestinal BD, whereas 46/47 (97%) patients with segmental
or diffuse distributions were confirmed as having CD. The
correct diagnosis of intestinal BD or CD could be reached in
92% retrospectively.
The colonic ulcers in BD have been classified as volcano-
type, geographic, and aphthous. Volcano-type ulcers were
defined as well-demarcated deep ulcers with nodular
margins and converging folds. Geographic-type ulcers were
defined as shallow ulcers with sharp edges. Aphthous-type
ulcers were defined as small, punched out shallow ulcers.5
Volcano-type ulcers respond poorly to medical treatment,
have a high recurrence rate, and often require surgery.4
Histologically, vasculitis of small veins and venules is
common in cases of intestinal BD, which is characterized by
a lymphocytic infiltrate. Behc¸et’s ulcers contain nonspecific
chronic inflammation, and the submucosal connective tis-
sue appears disrupted. Although granuloma formation is a
pathological hallmark of CD, chronic inflammation in the
form of longitudinal ulcers or a cobblestone appearance is
not characteristic of BD cases. There is less inflammationsurrounding the ulcers and the nearby mucosa is usually
grossly normal in BD as compared to CD.6
In this case, to make a definitive diagnosis of intestinal
BD with the clinical criteria was a difficult issue (the patient
matched one major and one minor criteria of the ISG and
had only 3 points on the ICBD, which put him in a possible
and not likely group), but the gross and histologic findings
did help. Thus, we made a decision and started the treat-
ment and follow-up.
Clinical data for the management of intestinal BD are
extremely limited because of the unknown etiology of the
disease. Available medical treatments include 5-
aminosalicylic acid (5-ASA), corticosteroids, and immuno-
suppressive drugs, such as those used to treat inflammatory
bowel diseases.7 The usual treatment strategy is using
glucocorticoids and 5-ASA first. In moderate to severe or
refractory cases, azathioprine and an anti-tumor necrosis
factor alpha agent (e.g., infliximab) have been effective in
several case series.
Patients diagnosed to have intestinal BD, aged < 25
years, who have a history of prior laparotomy or volcano-
shaped intestinal ulcers, have an increased risk of free
bowel perforation.4 The surgical procedure for complicated
intestinal BD and the length of bowel resection is contro-
versial. Some investigators have suggested that a right
hemicolectomy with as much as 60 cm or more of ileal
resection reduces the risk of recurrence. However, several
studies have recommended the removal of only the grossly
involved bowel, as it was found that the length of resection
did not affect the rates of recurrence or reoperation.
Because the intestinal lesions tend to be localized at the
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frequently require repeated operations that can eventually
result in the short bowel syndrome, a more conservative
operative procedure may be reasonable.
Simple closure of the perforated ulcers should not be an
option. During the operation, maximum attention must be
paid in order not to miss any small, shallow ulcers at
different locations.8
Perioperative steroids may delay the healing process,
inhibit fiber formation on the ulcer floor, and eventually
exacerbate the ulcers, which may provoke intestinal
perforation. Thus, routine perioperative steroid use is not
recommended.
One study showed that the cumulative recurrence rates
after surgical treatment were 29.2% at 2 years and 47.2% at
5 years; the cumulative reoperation rates were 12.5% at 2
years and 22.2% at 5 years. Multivariate analysis identified
volcano-shaped ulcers, higher C-reactive protein levels,
and a history of postoperative steroid therapy as indepen-
dent predictive factors for reoperation.9
The prognosis of BD involves a chronic, unpredictable
course with exacerbations and remissions which decrease in
frequency and severity over time. Death is mainly due to
major vessel disease and neurological involvement.
The pathergy seen in BD is a cutaneous hyperreactivity
followingminor trauma.Erythematouschangesandapurulent
discharge from the wound are often observed in cases of BD.
The healing process may take a longer time with more com-
plications, but the wound may still heal. As we witnessed in
this patient, his postoperative wound was complicated with
abscess formation, but the appendiceal stump healed well.
Fistula formation after the appendectomy is a very rare
complication (0.13% was reported in one study10) and usu-
ally occurs after complicated appendicitis such as gangre-
nous or perforated appendicitis.1 Of greater significance is
the fact that fistulas usually develop from the ileum in
cases of BD, but not from the appendiceal stump.
Although the treatment strategy has not been well
established, a careful review of the clinical history and
proper timing of a colonoscopy may help in the early
diagnosis of intestinal BD and could even prevent further
complications in some cases.
In conclusion, in cases of BD in endemic areas, with an
undulating clinical course, uncomplicated appendicitis, ayoung age, with no history of systemic disease or malnu-
trition in which the patient develops an enterocutaneous
fistula after an appendectomy, we must consider the
possibility of intestinal BD in the differential diagnosis
when wound healing is impaired or a fistula forms after
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